Go Pro
→ A new type of AI could unleash gains of up to 10,000% (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CorMedix Inc stock logo
CRMD
CorMedix
$7.19
-3.1%		$7.87
$6.13
▼
$13.02
$560.42M1.4812,982 shs1.13 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CorMedix Inc stock logo
CRMD
CorMedix
0.00%-8.41%-15.11%-17.83%-34.93%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CorMedix Inc stock logo
CRMD
CorMedix
$7.19
-3.1%		$7.87
$6.13
▼
$13.02
$560.42M1.4812,982 shs1.13 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CorMedix Inc stock logo
CRMD
CorMedix
0.00%-8.41%-15.11%-17.83%-34.93%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CorMedix Inc stock logo
CRMD
CorMedix
2.78
Moderate Buy$15.00108.62% Upside

Current Analyst Ratings Breakdown

Latest CRMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/23/2026
CorMedix Inc stock logo
CRMD
CorMedix
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$15.00
8/14/2026
CorMedix Inc stock logo
CRMD
CorMedix
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$13.00 ➝ $14.00
8/11/2026
CorMedix Inc stock logo
CRMD
CorMedix
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
7/7/2026
CorMedix Inc stock logo
CRMD
CorMedix
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$14.00 ➝ $13.00
(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CorMedix Inc stock logo
CRMD
CorMedix
$311.71M1.80$2.04 per share3.52$5.14 per share1.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CorMedix Inc stock logo
CRMD
CorMedix
$163.05M$2.143.3651.361.3340.49%40.52%20.61%11/11/2026 (Estimated)

Latest CRMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
CorMedix Inc stock logo
CRMD
CorMedix
$0.2380$0.29+$0.0520$0.29$96.04 million$101.93 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CorMedix Inc stock logo
CRMD
CorMedix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CorMedix Inc stock logo
CRMD
CorMedix
0.31
2.56
2.36

Institutional Ownership

CompanyInstitutional Ownership
CorMedix Inc stock logo
CRMD
CorMedix
34.18%

Insider Ownership

CompanyInsider Ownership
CorMedix Inc stock logo
CRMD
CorMedix
3.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
CorMedix Inc stock logo
CRMD
CorMedix
19177.94 million75.22 millionOptionable

Recent News About These Companies

Reviewing CorMedix (NASDAQ:CRMD) and Eyepoint Pharmaceuticals (NASDAQ:EYPT)
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31084149
CorMedix Inc (NASDAQ:CRMD) Stock Has Consensus Target Price of $15.00
October 3 at 2:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31081659
CorMedix Inc (NASDAQ:CRMD) Stock Now Rated "Moderate Buy" by Wall Street Analysts
October 3 at 2:13 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-cormedix-inc-nasdaq-crmd-stock-now-rated-moderate-buy-by-wall-street-analysts-2026-10-03/
150,656 Shares in CorMedix Inc $CRMD Acquired by Bank of America Corp DE
October 2 at 3:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-150656-shares-in-cormedix-inc-crmd-acquired-by-bank-of-america-corp-de-2026-10-02/
CorMedix (NASDAQ:CRMD) Shares Gap Up - Here's What Happened
September 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31048813
Oppenheimer Initiates Coverage on CorMedix (NASDAQ:CRMD)
September 25, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31047026
CorMedix Inc. : Oppenheimer maintient sa recommandation à l'achat
September 23, 2026  |  zonebourse.comZ
Oppenheimer initiates coverage of CorMedix at outperform
September 23, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/oppenheimer-initiates-coverage-of-cormedix-at-outperform/ar-AA2cQKqv
Oppenheimer avvia la copertura di CorMedix con rating outperform
September 23, 2026  |  it.investing.comhttps://it.investing.com/news/analyst-ratings/oppenheimer-avvia-la-copertura-di-cormedix-con-rating-outperform-93CH-3559202
CorMedix (NASDAQ:CRMD) Shares Gap Up - Still a Buy?
September 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-cormedix-nasdaq-crmd-shares-gap-up-still-a-buy-2026-09-23/
CorMedix (NASDAQ:CRMD) Coverage Initiated by Analysts at Oppenheimer
September 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-cormedix-nasdaq-crmd-coverage-initiated-by-analysts-at-oppenheimer-2026-09-23/
CorMedix出席富国银行第21届年度医疗健康大会：增长与风险并存
September 10, 2026  |  cn.investing.comhttps://cn.investing.com/news/transcripts/article-93CH-3558953
CorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by Brokerages
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-cormedix-inc-nasdaq-crmd-given-consensus-rating-of-moderate-buy-by-brokerages-2026-09-08/
CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged
September 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cormedix-crmd-just-tripled-profits-024505760.html
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet
September 7, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2985777/wall-street-analysts-think-cormedix-crmd-could-surge-67-73-read-this-before-placing-a-bet?cid=cs-stocknewsapi-ft-fundamental_analysis|consensus_price_target-2985777
Bank of New York Mellon Corp Takes Position in CorMedix Inc $CRMD
September 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-takes-position-in-cormedix-inc-crmd-2026-09-07/
243,232 Shares in CorMedix Inc $CRMD Purchased by Empowered Funds LLC
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-243232-shares-in-cormedix-inc-crmd-purchased-by-empowered-funds-llc-2026-09-04/
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354139/0/en/cormedix-therapeutics-to-participate-in-the-wells-fargo-healthcare-conference.html
CorMedix (CRMD) Upgraded to Buy: Here's Why
August 31, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2982700/cormedix-crmd-upgraded-to-buy-here-s-why?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_12_zacks_rank_upgrade-2982700
CorMedix Inc. (CRMD) Stock Earnings Call Transcripts - Yahoo Finance
August 21, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/CRMD/earnings-calls/
CorMedix (CRMD) Q2 2026 Earnings Call Transcript
August 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/cormedix-crmd-q2-2026-earnings-141459507.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

CorMedix stock logo

CorMedix NASDAQ:CRMD

$7.19 -0.23 (-3.10%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$7.32 +0.14 (+1.88%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas